Research ArticleCancer

In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy

See allHide authors and affiliations

Science Translational Medicine  21 Feb 2018:
Vol. 10, Issue 429, eaan3682
DOI: 10.1126/scitranslmed.aan3682
PDF Container

Navigate This Article